Searched for
PHARMACEUTICAL PRODUCTS
Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Prasol Chemicals IPO opens for bidding. Check GMP and other key detailsThe Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- Supreme Court ruling: Company criminal liability upheld even without director indictment in cheating casesThe Supreme Court ruled criminal cases against companies can proceed without specific individuals named. This decision impacts corporate cr...
- Prasol Chemicals mobilises Rs 150 cr from anchor investors ahead of IPOPrasol Chemicals has raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, which opens on September 8. The specia...
- Karnataka woos French companies for investments in manufacturing, R&D and aerospace sectorsKarnataka is seeking French investment in manufacturing and emerging sectors. Discussions were held with Roquette, bioMerieux, and Hutchins...
- Citrus peels may be more valuable than they look: 2026 USDA-backed study of 22 Florida-grown varieties and hybrids finds antioxidant, anti-inflammatory and potentially anti-cancer compoundsThe exploration of citrus peels by researchers unveils valuable antioxidant and anti-inflammatory compounds. Various citrus varieties and t...
- Govt mandates manual verification of imported drugs and medical devices due to SWIFT 2.0 system gapCustoms officers must now manually check import documents for healthcare products. This manual verification applies even to facilitated imp...
- Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...
- New FTAs open big export gains across key sectorsThe introduction of eight free trade agreements heralds a new era of duty-free market access, particularly benefiting the electronics, agri...
- RPG Life Sciences subsidiary acquires Raghava Life Sciences' API biz for Rs 135 crRPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...
- Prasol Chemicals fixes price band for Rs 500-cr IPO; issue to open on Sep 8Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Permira to buy 25.71% in Cloudnine Hospitals parent: CCI filingPermira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- More 'predictable' rules sought in Brazil to boost pharma tradeIndia seeks predictable regulatory pathways in Brazil to boost pharmaceutical exports. This move aims to ensure affordable and quality medi...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pactIndia seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trad...
Load More
